MegaMD Co. Ltd Cash Flow-to-Debt Ratio
MegaMD Co. Ltd cash flow-to-debt ratio. MegaMD Co. Ltd (133750) has a Cash Flow-to-Debt Ratio of -0.02x as of December 2025, meaning its operating cash flow of ₩-351.51 Million could theoretically repay 0% of its total liabilities (₩16.86 Billion) in one year. Check MegaMD Co. Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of MegaMD Co. Ltd (2014–2025)
Cash flow-to-debt ratio of MegaMD Co. Ltd from 2014 to 2025. Historical debt coverage capacity for MegaMD Co. Ltd across 12 annual periods. Check 133750 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
MegaMD Co. Ltd Cash Flow-to-Debt Ratio by Year (2014–2025)
MegaMD Co. Ltd cash flow-to-debt ratio by year from 2014 to 2025. Year-by-year debt coverage analysis for MegaMD Co. Ltd. For the full cash flow conversion analysis, see MegaMD Co. Ltd (133750) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.30x | ₩5.10 Billion | ₩16.86 Billion | ▼ -22.0% |
| 2024 | 0.39x | ₩8.39 Billion | ₩21.61 Billion | ▲ +726.8% |
| 2023 | 0.05x | ₩1.05 Billion | ₩22.47 Billion | ▲ +115.8% |
| 2022 | -0.30x | ₩-8.26 Billion | ₩27.81 Billion | ▼ -179.4% |
| 2021 | 0.37x | ₩17.94 Billion | ₩47.97 Billion | ▲ +19.5% |
| 2020 | 0.31x | ₩16.03 Billion | ₩51.23 Billion | ▲ +64.6% |
| 2019 | 0.19x | ₩9.69 Billion | ₩50.96 Billion | ▼ -45.9% |
| 2018 | 0.35x | ₩14.97 Billion | ₩42.61 Billion | ▲ +58.3% |
| 2017 | 0.22x | ₩7.60 Billion | ₩34.24 Billion | ▲ +27.4% |
| 2016 | 0.17x | ₩5.01 Billion | ₩28.73 Billion | ▼ -72.3% |
| 2015 | 0.63x | ₩18.12 Billion | ₩28.86 Billion | ▲ +68.3% |
| 2014 | 0.37x | ₩7.53 Billion | ₩20.18 Billion | — |